Bausch Health Companies
Stock Forecast, Prediction & Price Target
Bausch Health Companies (BHC) stock Price Target by analysts
$10
Potential upside: 27.56%
Bausch Health Companies price prediction
What is Bausch Health Companies stock analysts` prediction?
Bausch Health Companies stock forecast: Based on 1 Wall Street analysts` predicted price targets for Bausch Health Companies in the last 3 months, the avarage price target is $10, with a high forecast of $NaN. The average price target represents a 27.56% change from the last price of $7.84.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Bausch Health Companies stock Price Target by analysts
Full breakdown of analysts given Bausch Health Companies price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Douglas Miehm RBC Capital | 0% 0/1 | 11 months ago | $10 27.56% upside | $8.07 | TheFly | Previous targets (0) |
Les Sulewski Truist Financial | 0% 0/1 | about 1 year ago | $7 -10.70% downside | $5.69 | TheFly | Previous targets (0) |
Michael Freeman Raymond James | 0% 0/1 | about 1 year ago | $8 2.04% upside | $7.19 | TheFly | Previous targets (0) |
David Amsellem Piper Sandler | 0% 0/1 | over 1 year ago | $9 14.80% upside | $8.78 | StreetInsider | Previous targets (0) |
Doug Miehm RBC Capital | 0% 0/2 | over 1 year ago | $11 40.31% upside | $8.45 | StreetInsider | Previous targets (1) |
Glen Santangelo Jefferies | 0% 0/1 | over 1 year ago | $16 104.09% upside | $9.28 | StreetInsider | Previous targets (0) |
Doug Miehm RBC Capital | 0% 0/2 | over 1 year ago | $12 53.07% upside | $10.05 | StreetInsider | Previous targets (1) |
Unknown Piper Sandler | N/A | about 3 years ago | $6 -23.46% downside | $6.7 | Benzinga | N/A |
Unknown RBC Capital | N/A | about 3 years ago | $12 53.07% upside | $8.74 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $17 116.85% upside | $10.45 | Benzinga | N/A |
Bausch Health Companies Financial Estimates
Bausch Health Companies Revenue Estimates
Bausch Health Companies EBITDA Estimates
Bausch Health Companies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $8.43B N/A | $8.12B -3.67% | $8.75B 7.79% | Avg: $9.66B Low: $9.54B High: $9.81B avg. 10.37% | Avg: $9.99B Low: $9.85B High: $10.12B avg. 3.42% | Avg: $9.98B Low: $9.84B High: $10.11B avg. -0.11% | Avg: $8.64B Low: $8.52B High: $8.76B avg. -13.37% |
Net Income
% change YoY
| $-937M N/A | $-212M 77.37% | $-592M -179.24% | Avg: $389.18M Low: $310.16M High: $459.77M avg. 165.74% | Avg: $431.71M Low: $422.49M High: $437.79M avg. 10.92% | Avg: $1.85B Low: $1.82B High: $1.88B avg. 330.11% | Avg: $1.13B Low: $1.11B High: $1.15B avg. -38.61% |
EBITDA
% change YoY
| $2.58B N/A | $2.58B 0% | $2.24B -13.25% | Avg: $2.86B Low: $2.82B High: $2.90B avg. 27.61% | Avg: $2.95B Low: $2.91B High: $2.99B avg. 3.42% | Avg: $2.95B Low: $2.91B High: $2.99B avg. -0.11% | Avg: $2.56B Low: $2.52B High: $2.59B avg. -13.37% |
EPS
% change YoY
| -$2.61 N/A | -$0.59 77.39% | -$1.62 -174.57% | Avg: $1.05 Low: $0.85 High: $1.26 avg. 165.02% | Avg: $1.18 Low: $1.16 High: $1.2 avg. 12.02% | Avg: $5.09 Low: $4.99 High: $5.17 avg. 331.24% | Avg: $3.12 Low: $3.07 High: $3.18 avg. -38.61% |
Operating Expenses
% change YoY
| $4.83B N/A | $4.40B -8.95% | $5.23B 18.86% | Avg: $3.01B Low: $2.97B High: $3.06B avg. -42.42% | Avg: $3.11B Low: $3.07B High: $3.15B avg. 3.42% | Avg: $3.11B Low: $3.06B High: $3.15B avg. -0.11% | Avg: $2.69B Low: $2.65B High: $2.73B avg. -13.37% |
FAQ
What is Bausch Health Companies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 117.04% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is 310.16M, average is 389.18M and high is 459.77M.
What is Bausch Health Companies stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 0.07% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $9.54B, average is $9.66B and high is $9.81B.
What is Bausch Health Companies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 117.41% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is $0.85, average is $1.05 and high is $1.26.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Bausch Health Companies stock. The most successful analyst is Douglas Miehm.